138 related articles for article (PubMed ID: 16703748)
21. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
22. [Chemotherapy intensity importance in concurrent chemoradiotherapy of locally advanced cervical cancer].
Sirák I; Petera J; Odrázka K; Dolezel M; Zoul Z; Vaculíková M
Ceska Gynekol; 2006 Jul; 71(4):308-11. PubMed ID: 16956043
[TBL] [Abstract][Full Text] [Related]
23. A systematic overview of radiation therapy effects in cervical cancer (cervix uteri).
Einhorn N; Tropé C; Ridderheim M; Boman K; Sorbe B; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):546-56. PubMed ID: 14596512
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis.
Petrelli F; De Stefani A; Raspagliesi F; Lorusso D; Barni S
Gynecol Oncol; 2014 Jul; 134(1):166-71. PubMed ID: 24793000
[TBL] [Abstract][Full Text] [Related]
25. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study.
Lavey RS; Liu PY; Greer BE; Robinson WR; Chang PC; Wynn RB; Conrad ME; Jiang C; Markman M; Alberts DS
Gynecol Oncol; 2004 Oct; 95(1):145-51. PubMed ID: 15385124
[TBL] [Abstract][Full Text] [Related]
27. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
[TBL] [Abstract][Full Text] [Related]
28. [Concomitant chemoradiation in patients with cervix cancer].
Haie-Meder C; de Crevoisier R; Bruna A; Lhommé C; Pautier P; Morice P; Castaigne D; Bourhis J
Bull Cancer; 2005 Dec; 92(12):1032-8. PubMed ID: 16396749
[TBL] [Abstract][Full Text] [Related]
29. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
30. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix.
Souhami L; Seymour R; Roman TN; Stanimir GW; Trudeau M; Clark BG; Freeman CR
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):871-8. PubMed ID: 8244817
[TBL] [Abstract][Full Text] [Related]
31. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.
King M; McConkey C; Latief TN; Hartley A; Fernando I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):38-45. PubMed ID: 16477918
[TBL] [Abstract][Full Text] [Related]
32. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
33. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
[TBL] [Abstract][Full Text] [Related]
35. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
Wadler S; Goldberg G; Fields A; Anderson P; Beitler JJ; Sood B; Haynes H; Runowicz C
Semin Oncol; 1996 Aug; 23(4 Suppl 8):64-8. PubMed ID: 8783670
[TBL] [Abstract][Full Text] [Related]
36. A critical overview of concurrent chemoradiotherapy in cervical cancer.
Sardi JE; Boixadera MA; Sardi JJ
Curr Oncol Rep; 2004 Nov; 6(6):463-70. PubMed ID: 15485616
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
38. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
39. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?
Lehman M; Thomas G
Int J Gynecol Cancer; 2001; 11(2):87-99. PubMed ID: 11328406
[TBL] [Abstract][Full Text] [Related]
40. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
